loader image
Wednesday, November 26, 2025
71.2 F
McAllen
- Advertisement -

Memory Problems Linked to Slower Rate of Decline in Alzheimer’s

June is Alzheimer’s and Brain Awareness Month. Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

Translate to Spanish or other 102 languages!

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes
Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia. Image for illustration purposes

Mega Doctor News

- Advertisement -

CLEVELAND CLINIC – June is Alzheimer’s and Brain Awareness Month.

Research from Cleveland Clinic has found that initial memory problems are linked with a slower rate of decline in Alzheimer’s disease and dementia.

“What we found out was that people with early memory symptoms alone compared to people with early language problems or visual-spatial problems, they tend to have a slightly slower disease progression in terms of their functional abilities,” explained Jagan Pillai, MD, neurologist for Cleveland Clinic and lead author on the study.

- Advertisement -

Dr. Pillai said those with language problems, spatial ability and judgment issues seemed to be affected more over a period of time – specifically in their daily functional abilities.

He said it seems to make sense since a person with just memory difficulties could find other ways to compensate, like keeping track of what they’re doing by recording themselves or writing down notes. That would then allow them to remain functional.

He also noted that memory difficulties come from another part of the brain than language problems, for example. So, how the disease progresses could be different.

“The portion of the brain that is first impacted by the disease tends to determine the symptoms that goes along with the disease and also the kind of progression from there to other regions,” said Dr. Pillai.

- Advertisement -

Dr. Pillai said having this information available can better help physicians diagnose people and prepare them for the future.

It can also be useful for researchers when it comes to testing different medications to treat Alzheimer’s disease.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Mayo Clinic Researchers Identify Why Some Lung Tumors Respond Well to Immunotherapy

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. 

$4 Million Study on Glucagon Hormone’s Role in Diabetes, Obesity

From metabolic villain to hero? The hormone glucagon that raises blood sugar is now getting a second look to see how it actually contributes to insulin secretion, glucose regulation and energy balance in people with obesity.

New Pill Reduces ‘Bad’ Cholesterol Levels by Almost 60%

A recent study published in JAMA on November 9, investigates a drug called enlicitide. 

Importance of Knowing Family Health History

Thanksgiving is Family Health History Day. As you’re gathered with your parents, siblings and other relatives, consider talking to them about their health. 
- Advertisement -
×